01.10.2014 • News

Huntsman Starts Work on MDI Expansion

Capitalizing on the widening availability of shale-gas derived feedstock, Huntsman is doubling MDI output at Geismar, Louisiana, by 400,000 t/y up to 2018.

In a preliminary step, the company has begun engineering work on an interim expansion to add 50,000 t/y by next year, lifting output to 500,000 t/y. When construction is complete, output capability will rise to 950,000 t/y.

"Shale gas has significantly improved the economics of investing in US facilities and has helped our Geismar facility to establish a strong cost leadership position," said Anthony P. Hankins, president of Huntsman Polyurethanes.

"The planned additional capacity will reinforce this position and establish the plant as a truly global supplier Hankins added.

With demand for MDI-based polyurethanes seen as growing at around 8% annually, Huntsman is investing in new upstream and downstream capacity at several locations."

The company's Geismar site is regarded as the US market's largest integrated producer. It also operates world-scale MDI plants at Rotterdam in the Netherlands, along with its joint venture with BASF at Shanghai, China.

In the first quarter of 2015, the doubling of output at the Shanghai jv to 480,000 is planned to be completed.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read